Clorox Company (The) (CLX) Shares Sold by KAMES CAPITAL plc

KAMES CAPITAL plc lowered its position in Clorox Company (The) (NYSE:CLX) by 5.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 340,458 shares of the company’s stock after selling 20,760 shares during the period. KAMES CAPITAL plc owned approximately 0.26% of Clorox Company (The) worth $45,366,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. FMR LLC boosted its stake in shares of Clorox Company (The) by 8.1% in the fourth quarter. FMR LLC now owns 97,861 shares of the company’s stock worth $11,746,000 after buying an additional 7,357 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Clorox Company (The) by 5.5% in the fourth quarter. Thrivent Financial for Lutherans now owns 4,565 shares of the company’s stock worth $548,000 after buying an additional 240 shares during the last quarter. Quadrature Capital Ltd boosted its stake in shares of Clorox Company (The) by 1,044.0% in the fourth quarter. Quadrature Capital Ltd now owns 94,059 shares of the company’s stock worth $11,292,000 after buying an additional 85,837 shares during the last quarter. HighPoint Advisor Group LLC boosted its stake in shares of Clorox Company (The) by 3.0% in the fourth quarter. HighPoint Advisor Group LLC now owns 43,247 shares of the company’s stock worth $5,509,000 after buying an additional 1,245 shares during the last quarter. Finally, Kentucky Retirement Systems bought a new stake in shares of Clorox Company (The) during the fourth quarter worth $1,121,000. Institutional investors and hedge funds own 70.56% of the company’s stock.

Shares of Clorox Company (CLX) traded down 0.18% during trading on Friday, hitting $134.49. The stock had a trading volume of 750,794 shares. The stock has a market capitalization of $17.32 billion, a price-to-earnings ratio of 26.57 and a beta of 0.40. The stock’s 50 day moving average is $134.79 and its 200 day moving average is $133.07. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the previous year, the company posted $1.30 EPS. Clorox Company (The)’s revenue was up 2.9% on a year-over-year basis. On average, equities research analysts expect that Clorox Company will post $5.69 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 4th. Investors of record on Wednesday, July 19th were given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.50%. The ex-dividend date of this dividend was Monday, July 17th. This is a boost from Clorox Company (The)’s previous quarterly dividend of $0.80. Clorox Company (The)’s payout ratio is 63.04%.

CLX has been the topic of a number of research reports. Jefferies Group LLC initiated coverage on Clorox Company (The) in a research report on Tuesday, April 18th. They set a “hold” rating and a $138.00 price target on the stock. Vetr cut Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target on the stock. in a research report on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 price target on Clorox Company (The) and gave the stock a “hold” rating in a research report on Monday, April 24th. BMO Capital Markets reiterated a “buy” rating and set a $136.00 price target on shares of Clorox Company (The) in a research report on Thursday, May 4th. Finally, UBS AG reiterated a “sell” rating and set a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $129.13.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.